Search
for
Sort by
Research 121–150 of 410
- Evaluation of trichodynia (hair pain) during chemotherapy or tamoxifen treatment in breast cancer patients
- Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner
- Baldness and testicular cancer: the EPSAM case-control study
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Potential Use of Spin Traps to Control ROS in Antipollution Cosmetics—A Review
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Atypical fibroxanthoma of the scalp following hair transplantation in a 35-year-old male
- Monoclonal Antibody Against Prolactin Receptor: A Randomized Placebo-Controlled Study Evaluating Safety, Tolerability, and Pharmacokinetics of Repeated Subcutaneous Administrations in Postmenopausal Women
- Cutaneous Reactions to Drugs
- Retrospective evaluation of Penguin Cold Caps for chemotherapy-induced alopecia
- Morphological characteristics and notes of the skin in preclinical toxicity assessment
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey
- Scalp hypothermia for the prevention of chemotherapy-induced alopecia in breast cancer
- Aromatase inhibitor–induced hair loss in two adolescents
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- Real-World Safety Profile of Generic Palbociclib in Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer: A Prospective Observational Study in Iraq”
- Efficacy of Scalp Cooling combined with DHL-HisZnNa Lotion in the Prevention of Chemotherapy-Induced Alopecia in Patients with Breast Cancer
- Skin manifestations of hyperandrogenism: an update
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer
- Innovations for cost-effective and eco-friendly solutions to combat chemotherapy-induced alopecia: a narrative systematic review
- Ayurveda-Based Supportive Care Using Guduchi, Ashwagandha, and Curcumin for Breast Cancer Patients: A Pilot Observational Study on Quality of Life and Safety
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- CASE OF EARLY PUBERTAL DEVELOPMENT IN A 3-YEAR-OLD GIRL: CONSIDERING RARE PERIPHERAL CAUSES
- The causes of age-related alopecia from the point of view of modern morphology